Carcinoid syndrome (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Carcinoid syndrome" in English language version.

refsWebsite
Global rank English rank
4th place
4th place
2nd place
2nd place
11th place
8th place
low place
low place
3,771st place
2,605th place
9,011th place
6,167th place

doi.org

merckvetmanual.com

neuroendocrine.org.au

nih.gov

pubmed.ncbi.nlm.nih.gov

  • Pandit, Sudha; Annamaraju, Pavan; Bhusal, Kamal (2022), "Carcinoid Syndrome", StatPearls, Treasure Island (FL): StatPearls Publishing, PMID 28846309, retrieved 2023-01-16
  • Rubin de Celis Ferrari AC; Glasberg, J.; Riechelmann, R. P. (2018). "Carcinoid syndrome: Update on the pathophysiology and treatment". Clinics (Sao Paulo, Brazil). 73 (suppl 1): e490s. doi:10.6061/clinics/2018/e490s. PMC 6096975. PMID 30133565.
  • Ram, P.; Penalver, J. L.; Lo KBU; Rangaswami, J.; Pressman, G. S. (2019). "Carcinoid Heart Disease: Review of Current Knowledge". Texas Heart Institute Journal. 46 (1): 21–27. doi:10.14503/THIJ-17-6562. PMC 6378997. PMID 30833833.
  • Guilmette, J.; Nosé, V. (2019). "Paraneoplastic syndromes and other systemic disorders associated with neuroendocrine neoplasms". Seminars in Diagnostic Pathology. 36 (4): 229–239. doi:10.1053/j.semdp.2019.03.002. PMID 30910348. S2CID 85514650.
  • Tsoli, M.; Chatzellis, E.; Koumarianou, A.; Kolomodi, D.; Kaltsas, G. (2019). "Current best practice in the management of neuroendocrine tumors". Therapeutic Advances in Endocrinology and Metabolism. 10. doi:10.1177/2042018818804698. PMC 6378464. PMID 30800264.
  • Gade AK, Olariu E, Douthit NT (March 2020). "Carcinoid Syndrome: A Review". Cureus. 12 (3): e7186. doi:10.7759/cureus.7186. PMC 7124884. PMID 32257725.
  • Ito, T.; Lee, L.; Jensen, R. T. (2018). "Carcinoid-syndrome: Recent advances, current status and controversies". Current Opinion in Endocrinology, Diabetes, and Obesity. 25 (1): 22–35. doi:10.1097/MED.0000000000000376. PMC 5747542. PMID 29120923.
  • Nobels FR, Kwekkeboom DJ, Bouillon R, Lamberts SW (June 1998). "Chromogranin A: its clinical value as marker of neuroendocrine tumours". European Journal of Clinical Investigation. 28 (6): 431–440. doi:10.1046/j.1365-2362.1998.00305.x. PMID 9693933. S2CID 37911197.

ncbi.nlm.nih.gov

  • Pandit, Sudha; Annamaraju, Pavan; Bhusal, Kamal (2022), "Carcinoid Syndrome", StatPearls, Treasure Island (FL): StatPearls Publishing, PMID 28846309, retrieved 2023-01-16
  • Rubin de Celis Ferrari AC; Glasberg, J.; Riechelmann, R. P. (2018). "Carcinoid syndrome: Update on the pathophysiology and treatment". Clinics (Sao Paulo, Brazil). 73 (suppl 1): e490s. doi:10.6061/clinics/2018/e490s. PMC 6096975. PMID 30133565.
  • Ram, P.; Penalver, J. L.; Lo KBU; Rangaswami, J.; Pressman, G. S. (2019). "Carcinoid Heart Disease: Review of Current Knowledge". Texas Heart Institute Journal. 46 (1): 21–27. doi:10.14503/THIJ-17-6562. PMC 6378997. PMID 30833833.
  • Tsoli, M.; Chatzellis, E.; Koumarianou, A.; Kolomodi, D.; Kaltsas, G. (2019). "Current best practice in the management of neuroendocrine tumors". Therapeutic Advances in Endocrinology and Metabolism. 10. doi:10.1177/2042018818804698. PMC 6378464. PMID 30800264.
  • Gade AK, Olariu E, Douthit NT (March 2020). "Carcinoid Syndrome: A Review". Cureus. 12 (3): e7186. doi:10.7759/cureus.7186. PMC 7124884. PMID 32257725.
  • Ito, T.; Lee, L.; Jensen, R. T. (2018). "Carcinoid-syndrome: Recent advances, current status and controversies". Current Opinion in Endocrinology, Diabetes, and Obesity. 25 (1): 22–35. doi:10.1097/MED.0000000000000376. PMC 5747542. PMID 29120923.

semanticscholar.org

api.semanticscholar.org

uptodate.com